NEW YORK, Nov. 30 (GenomeWeb News) - Gene Network Sciences will provide computer models to improve clinical trial success rates for cancer patients at the Mary Crowley Medical Research Center, the company said today.
Under the partnership agreement, Gene Network will be compensated per-patient.
The Dallas, TX-based medical facility will use biosimulation to test which therapies have the best clinical outcomes based on actual cancer patients' individual gene-expression data, the company said.
Gene Network processes biological data to develop computer simulations of cells, tissues, and organs for the purpose of improving cancer drug research and patient treatment, the firm said. By filtering out drug candidates in computer models fed with patient data, specialists may be able to better identify better drugs.